BRIEF published on 11/27/2025 at 00:20, 8 days 9 hours ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/27/2025 at 00:15, 8 days 10 hours ago Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets Transgene resumes trading of shares on Euronext Paris following capital increase results publication Euronext Paris Shares Trading Capital Increase Transgene
BRIEF published on 11/26/2025 at 23:37, 8 days 10 hours ago Transgene Raises €105 Million for Cancer Vaccine Development Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE published on 11/26/2025 at 23:32, 8 days 10 hours ago Transgene Successfully Completes a Fundraising of c. €105 Million Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028 Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF published on 11/25/2025 at 22:06, 9 days 12 hours ago Transgene raises funds with the Talisman project Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF published on 11/25/2025 at 21:47, 9 days 12 hours ago Temporary suspension of trading in Transgene shares Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/25/2025 at 21:42, 9 days 12 hours ago Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results. Trading to resume on November 27, 2025 Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 20:46, 9 days 13 hours ago Temporary Suspension of Trading in Transgene Shares on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Trading Suspended
PRESS RELEASE published on 11/25/2025 at 20:41, 9 days 13 hours ago Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 19:20, 9 days 14 hours ago Transgene Launches €105 Million Fundraising Initiative Biotechnology Investment Transgene Fundraising Myvac® Program Cancer Vaccine Development Institutional And Retail Offerings
Published on 12/05/2025 at 02:35, 7 hours 44 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 19 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 14 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 19 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 38 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 49 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 13 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 18 minutes ago Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 08:45, 1 hour 34 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 19 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 34 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 34 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
